Theseus Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Description of Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2022)
- Offer Letter, dated July 1, 2021, by and between Theseus Pharmaceuticals, Inc. and Iain D. Dukes (Filed With SEC on September 15, 2021)
- Offer Letter, dated May 25, 2021, by and between Theseus Pharmaceuticals, Inc. and Kathy Yi (Filed With SEC on September 15, 2021)
- Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Bradford D. Dahms (Filed With SEC on September 15, 2021)
- Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Victor M. Rivera (Filed With SEC on September 15, 2021)
- Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and David C. Dalgarno (Filed With SEC on September 15, 2021)
- Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and William C. Shakespeare (Filed With SEC on September 15, 2021)
- Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson (Filed With SEC on September 15, 2021)